166 related articles for article (PubMed ID: 10465465)
1. The Royal College of Radiologists' Clinical Oncology Information Network. Guidelines on the non-surgical management of breast cancer.
Clin Oncol (R Coll Radiol); 1999; 11(3):S90-133. PubMed ID: 10465465
[No Abstract] [Full Text] [Related]
2. [Radiotherapy of breast carcinoma. 2005 version].
Organgruppe "Mammakarzinom" der DEGRO
Strahlenther Onkol; 2006 Feb; 182 Suppl 1():4-28. PubMed ID: 16613299
[No Abstract] [Full Text] [Related]
3. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of protocol B-17: intraductal carcinoma.
Cutuli B
Cancer; 2000 Apr; 88(8):1976-7. PubMed ID: 10760777
[No Abstract] [Full Text] [Related]
4. [Radiotherapy and tamoxifen facilitate breast-preserving treatment of ductal carcinoma in situ of the breast].
Sautter-Bihl ML
Strahlenther Onkol; 1999 Dec; 175(12):620-1. PubMed ID: 10633790
[No Abstract] [Full Text] [Related]
5. Ductal carcinoma in situ of the breast.
Ellison MC; Kenney PJ
N Engl J Med; 2004 Jul; 351(4):399-402; author reply 399-402. PubMed ID: 15278956
[No Abstract] [Full Text] [Related]
6. 1998-1999 patterns of care study process survey of national practice patterns using breast-conserving surgery and radiotherapy in the management of stage I-II breast cancer.
Pierce LJ; Moughan J; White J; Winchester DP; Owen J; Wilson JF
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):183-92. PubMed ID: 15850920
[TBL] [Abstract][Full Text] [Related]
7. DEGRO practical guidelines for radiotherapy of breast cancer I: breast-conserving therapy.
Sautter-Bihl ML; Budach W; Dunst J; Feyer P; Haase W; Harms W; Sedlmayer F; Souchon R; Wenz F; Sauer R; ;
Strahlenther Onkol; 2007 Dec; 183(12):661-6. PubMed ID: 18040609
[TBL] [Abstract][Full Text] [Related]
8. Forty year experience with carcinoma of the male breast.
Vanderbilt PC; Warren SE
Surg Gynecol Obstet; 1971 Oct; 133(4):629-33. PubMed ID: 4328853
[No Abstract] [Full Text] [Related]
9. [Therapy of pronounced pleural and pericardial effusion in metastatic breast cancer with local mitoxantrone and radiation therapy. Presentation of the intrapleural cytologic findings during this therapy].
Blohmer JU; Kohls A; Lau HU
Zentralbl Gynakol; 1993; 115(2):86-9. PubMed ID: 8383901
[TBL] [Abstract][Full Text] [Related]
10. [Value of radiotherapy in breast cancer. Breast preservation rises to 80%].
Seegenschmiedt MH; Strittmatter HJ
MMW Fortschr Med; 2003 Jun; 145(25):26-30. PubMed ID: 12891848
[TBL] [Abstract][Full Text] [Related]
11. [Comparative evaluation of the methods of radiation therapy in recurrences of breast cancer].
Kozlova AV
Med Radiol (Mosk); 1971 Feb; 16(2):37-41. PubMed ID: 4377018
[No Abstract] [Full Text] [Related]
12. Understanding ductal carcinoma in situ: a step in the right direction.
Morrow M
Cancer; 1999 Aug; 86(3):375-7. PubMed ID: 10430242
[No Abstract] [Full Text] [Related]
13. MammoSite balloon brachytherapy: errors, pitfalls, and technical issues for a practicing surgeon.
Forszpaniak J
Breast J; 2006; 12(5 Suppl 2):S191-5. PubMed ID: 16959000
[TBL] [Abstract][Full Text] [Related]
14. Radiation therapy for ductal carcinoma in situ: is it really worth it?
Thorat MA; Parmar V; Nadkarni MS; Badwe RA
J Clin Oncol; 2007 Feb; 25(4):461-2; author reply 462. PubMed ID: 17264349
[No Abstract] [Full Text] [Related]
15. Five-year outcome of patients classified in the "unsuitable" category using the American Society of Therapeutic Radiology and Oncology (ASTRO) Consensus Panel guidelines for the application of accelerated partial breast irradiation: an analysis of patients treated on the American Society of Breast Surgeons MammoSite® Registry trial.
Beitsch P; Vicini F; Keisch M; Haffty B; Shaitelman S; Lyden M
Ann Surg Oncol; 2010 Oct; 17 Suppl 3():219-25. PubMed ID: 20853036
[TBL] [Abstract][Full Text] [Related]
16. Ductal carcinoma in situ and microinvasive disease. American College of Radiology. ACR Appropriateness Criteria.
Rabinovitch RA; Solin LJ; Shank BM; Haffty BG; Halberg FE; Martinez AA; McCormick B; McNeese MD; Mendenhall NP; Mitchell SE; Taylor ME; Singletary SE; Leibel S
Radiology; 2000 Jun; 215 Suppl():1137-52. PubMed ID: 11037538
[No Abstract] [Full Text] [Related]
17. The role of aromatase inhibitors in the management of ductal carcinoma in situ with an estrogen receptor-positive/progesterone receptor-negative/Her-2/neu receptor-positive pattern.
Altundag K; Bulut N; Sari E; Harputluoglu H
Am J Surg; 2007 Aug; 194(2):272-3. PubMed ID: 17618822
[No Abstract] [Full Text] [Related]
18. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
[TBL] [Abstract][Full Text] [Related]
19. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F
Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy and tamoxifen after breast-conserving surgery for DCIS.
Cunnick GH; Mokbel K
Int J Fertil Womens Med; 2004; 49(5):237-8. PubMed ID: 15633483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
